申请人:Boehringer Ingelheim GmbH
公开号:US03993683A1
公开(公告)日:1976-11-23
Compounds of the formula ##SPC1## Wherein R.sub.1 is hydrogen, fluorine, bromine, methyl, methoxy, methylthio, nitro, cyano or, when A is other than methylene, R.sub.2 is hydrogen, R.sub.3 is carboxyl, m is 2 and n is 0, also chlorine; R.sub.2 is hydrogen or fluorine; R.sub.3 is hydrogen, methyl, hydroxymethyl, carboxyl, (alkoxy of 1 to 6 carbon atoms)-carbonyl, methoxy-(alkoxy of 1 to 6 carbon atoms)-carbonyl, (alkenyloxy of 2 to 6 carbon atoms)-carbonyl, (aralkoxy of 7 to 12 carbon atoms)-carbonyl, phenoxy-carbonyl, pyridylmethoxy-carbonyl, amino-carbonyl, (alkyl of 1 to 3 carbon atoms-amino)-carbonyl, (dialkyl of 1 to 3 carbon atoms-amino)-carbonyl, phenylamino-carbonyl, morpholino-carbonyl, piperidino-carbonyl, thiomorpholino-carbonyl, (1-oxidothiomorpholino)-carbonyl or (1,1-dioxido-thiomorpholino)-carbonyl; A is methylene, (alkyl of 1 to 3 carbon atoms)-methylene, di-(alkyl of 1 to 3 carbon atoms)-methylene, hydroxymethyl-methylene, hydroxymethylene or carbonyl; m is 1 or 2; and n is 0, 1, 2 or 3; And, when R.sub.3 is carboxyl, non-toxic salts thereof formed with an inorganic or organic base. The compounds as well as the salts are useful as antithrombotics, anticholesteremics and anticoagulants.
式为##SPC1##的化合物,其中R.sub.1为氢、氟、溴、甲基、甲氧基、甲硫基、硝基、氰基或当A不是亚甲基时,R.sub.2为氢,R.sub.3为羧基,m为2,n为0,还有氯;R.sub.2为氢或氟;R.sub.3为氢、甲基、羟甲基、羧基、(1至6个碳原子的烷氧基)-羰基、甲氧基-(1至6个碳原子的烷氧基)-羰基、(2至6个碳原子的烯氧基)-羰基、(7至12个碳原子的芳基氧基)-羰基、苯氧基-羰基、吡啶甲氧基-羰基、氨基-羰基、(1至3个碳原子的烷基氨基)-羰基、(1至3个碳原子的二烷基氨基)-羰基、苯基氨基-羰基、吗啉基-羰基、哌啶基-羰基、硫吗啉基-羰基、(1-氧代硫吗啉基)-羰基或(1,1-二氧代硫吗啉基)-羰基;A为亚甲基,(1至3个碳原子的烷基)-亚甲基,二(1至3个碳原子的烷基)-亚甲基,羟甲基-亚甲基,羟亚甲基或羰基;m为1或2;n为0、1、2或3;当R.sub.3为羧基时,与无机或有机碱形成的非毒性盐。这些化合物以及盐可用作抗血栓、抗胆固醇和抗凝剂。